Literature DB >> 3493434

Immunotherapy of cancer: the end of the beginning?

J R Durant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3493434     DOI： 10.1056/NEJM198704093161509

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Cancer immunotherapy--the endgame begins.

Authors:  Louis M Weiner
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

2.  Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses.

Authors:  Andrew C Liu; Krishna Patel; Ramya Dhatri Vunikili; Kipp W Johnson; Fahad Abdu; Shivani Kamath Belman; Benjamin S Glicksberg; Pratyush Tandale; Roberto Fontanez; Oommen K Mathew; Andrew Kasarskis; Priyabrata Mukherjee; Lakshminarayanan Subramanian; Joel T Dudley; Khader Shameer
Journal:  Brief Bioinform       Date:  2020-07-15       Impact factor: 11.622

3.  Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2. Preliminary results in children with acute lymphocytic leukemia and neuroblastoma.

Authors:  P M Anderson; F H Bach; A C Ochoa
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Natural-killer-stimulatory effect of combined low-dose interleukin-2 and interferon beta in hairy-cell leukemia patients.

Authors:  A M Liberati; V De Angelis; M Fizzotti; M Schippa; M Cecchini; D Adiuto; F Di Clemente; L Palmisano; E Micozzi; M Zuccaccia
Journal:  Cancer Immunol Immunother       Date:  1994-05       Impact factor: 6.968

Review 5.  Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review.

Authors:  Chang Liu; Navindra P Seeram; Hang Ma
Journal:  Cancer Cell Int       Date:  2021-04-27       Impact factor: 5.722

6.  Role of CD68 in tumor immunity and prognosis prediction in pan-cancer.

Authors:  Jingwei Zhang; Shuwang Li; Fangkun Liu; Kui Yang
Journal:  Sci Rep       Date:  2022-05-12       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.